The Evolving Classification of Pulmonary Hypertension
Authors:
- Michelle FoshatMFMichelle Foshat
- Nahal BoroumandNBNahal Boroumand
- 16 March 2016
- journal article
- review article
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 141 (5) , 696-703
Abstract
Context.—: An explosion of information on pulmonary hypertension has occurred during the past few decades. The perception of this disease has shifted from purely clinical to incorporate new knowledge of the underlying pathology. This transfer has occurred in light of advancements in pathophysiology, histology, and molecular medical diagnostics. Objectives.—: To update readers about the evolving understanding of the etiology and pathogenesis of pulmonary hypertension and to demonstrate how pathology has shaped the current classification. Data Sources.—: Information presented at the 5 World Symposia on pulmonary hypertension held since 1973, with the last meeting occurring in 2013, was used in this review. Conclusions.—: Pulmonary hypertension represents a heterogeneous group of disorders that are differentiated based on differences in clinical, hemodynamic, and histopathologic features. Early concepts of pulmonary hypertension were largely influenced by pharmacotherapy, hemodynamic function, and clinical presentation of the disease. The initial nomenclature for pulmonary hypertension segregated the clinical classifications from pathologic subtypes. Major restructuring of this disease classification occurred between the first and second symposia, which was the first to unite clinical and pathologic information in the categorization scheme. Additional changes were introduced in subsequent meetings, particularly between the third and fourth World Symposia meetings, when additional pathophysiologic information was gained. Discoveries in molecular diagnostics significantly progressed the understanding of idiopathic pulmonary arterial hypertension. Continued advancements in imaging modalities, mechanistic pathogenicity, and molecular biomarkers will enable physicians to define pulmonary hypertension phenotypes based on the pathobiology and allow for treatment customization.Keywords
This publication has 30 references indexed in Scilit:
- A tribute: Abel Ayerza and pulmonary hypertensionEuropean Respiratory Review, 2011
- One Hundred Years of Research in the Pathogenesis of Pulmonary HypertensionAmerican Journal of Respiratory Cell and Molecular Biology, 2005
- Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2005
- A Century of Pulmonary HemodynamicsAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Primary pulmonary arterial hypertensionJACC, 2004
- Primary pulmonary hypertensionThe American Journal of Medicine, 1951
- PATHOLOGY OF THE VESSELS OF THE PULMONARY CIRCULATIONArchives of internal medicine (1908), 1935
- PATHOLOGY OF THE VESSELS OF THE PULMONARY CIRCULATIONArchives of internal medicine (1908), 1935
- PATHOLOGY OF THE VESSELS OF THE PULMONARY CIRCULATIONArchives of internal medicine (1908), 1935
- PATHOLOGY OF THE VESSELS OF THE PULMONARY CIRCULATIONArchives of internal medicine (1908), 1935